Subsequently, 4% of JAK2 V617F-negative PV patients were found to have a cluster of JAK2 gene mutations in exon 12 (microdeletions and point mutations affecting amino acid residues at position 537–542 of the JAK2 protein [6,7,8,9]). The gene discussed is JAK2; the disease is acquired polycythemia vera.